PittsburghV1, Istex, Corpus, bibRecord, 001693

Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity

Identifieur interne : 001693 ( Istex/Corpus ); précédent : 001692; suivant : 001694

Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity

Auteurs : John C. Hiserodt ; William H. Chambers

Source :

Annals of the New York Academy of Sciences [ 0077-8923 ] ; 1988-08.

RBID : ISTEX:63BCE4B9204D80FCA9A3521E82CB3124983E81A2

English descriptors

Url:

https://api.istex.fr/document/63BCE4B9204D80FCA9A3521E82CB3124983E81A2/fulltext/pdf

DOI: 10.1111/j.1749-6632.1988.tb36357.x

Links to Exploration step

ISTEX:63BCE4B9204D80FCA9A3521E82CB3124983E81A2

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity</title>
<author><name sortKey="Hiserodt, John C" sort="Hiserodt, John C" uniqKey="Hiserodt J" first="John C." last="Hiserodt">John C. Hiserodt</name>
<affiliation><mods:affiliation>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Chambers, William H" sort="Chambers, William H" uniqKey="Chambers W" first="William H." last="Chambers">William H. Chambers</name>
<affiliation><mods:affiliation>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:63BCE4B9204D80FCA9A3521E82CB3124983E81A2</idno>
<date when="1988" year="1988">1988</date>
<idno type="doi">10.1111/j.1749-6632.1988.tb36357.x</idno>
<idno type="url">https://api.istex.fr/document/63BCE4B9204D80FCA9A3521E82CB3124983E81A2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001693</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001693</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity</title>
<author><name sortKey="Hiserodt, John C" sort="Hiserodt, John C" uniqKey="Hiserodt J" first="John C." last="Hiserodt">John C. Hiserodt</name>
<affiliation><mods:affiliation>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Chambers, William H" sort="Chambers, William H" uniqKey="Chambers W" first="William H." last="Chambers">William H. Chambers</name>
<affiliation><mods:affiliation>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Annals of the New York Academy of Sciences</title>
<title level="j" type="alt">ANNALS OF NEW YORK ACADEMY SCIENCES</title>
<idno type="ISSN">0077-8923</idno>
<idno type="eISSN">1749-6632</idno>
<imprint><biblScope unit="vol">532</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="395">395</biblScope>
<biblScope unit="page" to="404">404</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1988-08">1988-08</date>
</imprint>
<idno type="ISSN">0077-8923</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0077-8923</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acad</term>
<term>Adherent population</term>
<term>Adoptive immunotherapy</term>
<term>Assay</term>
<term>Cytolysin</term>
<term>Cytolytic</term>
<term>Cytolytic activity</term>
<term>Cytotoxic</term>
<term>Cytotoxic activity</term>
<term>Cytotoxicity</term>
<term>Cytotoxicity assays</term>
<term>Direct cellmediated cytotoxicity</term>
<term>Direct cytotoxicity</term>
<term>Effector</term>
<term>Effector cells</term>
<term>Golgi apparatus</term>
<term>Granule</term>
<term>High concentrations</term>
<term>High levels</term>
<term>Hiserodt</term>
<term>Hiserodt chambers</term>
<term>Immunol</term>
<term>Intracytoplasmic granules</term>
<term>Killer cells</term>
<term>Lytic</term>
<term>Mediator</term>
<term>Natl</term>
<term>Natural cytotoxic cells</term>
<term>Percent cytotoxicity</term>
<term>Phorbol ester</term>
<term>Primary mediator</term>
<term>Proc</term>
<term>Soluble cytotoxic factors</term>
<term>Target cells</term>
<term>Uptake assay</term>
<term>York academy</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Acad</term>
<term>Adherent population</term>
<term>Adoptive immunotherapy</term>
<term>Assay</term>
<term>Cytolysin</term>
<term>Cytolytic</term>
<term>Cytolytic activity</term>
<term>Cytotoxic</term>
<term>Cytotoxic activity</term>
<term>Cytotoxicity</term>
<term>Cytotoxicity assays</term>
<term>Direct cellmediated cytotoxicity</term>
<term>Direct cytotoxicity</term>
<term>Effector</term>
<term>Effector cells</term>
<term>Golgi apparatus</term>
<term>Granule</term>
<term>High concentrations</term>
<term>High levels</term>
<term>Hiserodt</term>
<term>Hiserodt chambers</term>
<term>Immunol</term>
<term>Intracytoplasmic granules</term>
<term>Killer cells</term>
<term>Lytic</term>
<term>Mediator</term>
<term>Natl</term>
<term>Natural cytotoxic cells</term>
<term>Percent cytotoxicity</term>
<term>Phorbol ester</term>
<term>Primary mediator</term>
<term>Proc</term>
<term>Soluble cytotoxic factors</term>
<term>Target cells</term>
<term>Uptake assay</term>
<term>York academy</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>wiley</corpusName>
<keywords><teeft><json:string>cytotoxicity</json:string>
<json:string>cytotoxic</json:string>
<json:string>immunol</json:string>
<json:string>effector</json:string>
<json:string>target cells</json:string>
<json:string>proc</json:string>
<json:string>cytolysin</json:string>
<json:string>effector cells</json:string>
<json:string>cytolytic</json:string>
<json:string>mediator</json:string>
<json:string>natl</json:string>
<json:string>hiserodt</json:string>
<json:string>acad</json:string>
<json:string>granule</json:string>
<json:string>lytic</json:string>
<json:string>cytotoxic activity</json:string>
<json:string>assay</json:string>
<json:string>percent cytotoxicity</json:string>
<json:string>direct cytotoxicity</json:string>
<json:string>york academy</json:string>
<json:string>soluble cytotoxic factors</json:string>
<json:string>killer cells</json:string>
<json:string>intracytoplasmic granules</json:string>
<json:string>hiserodt chambers</json:string>
<json:string>phorbol ester</json:string>
<json:string>primary mediator</json:string>
<json:string>cytotoxicity assays</json:string>
<json:string>high concentrations</json:string>
<json:string>direct cellmediated cytotoxicity</json:string>
<json:string>natural cytotoxic cells</json:string>
<json:string>adoptive immunotherapy</json:string>
<json:string>high levels</json:string>
<json:string>adherent population</json:string>
<json:string>golgi apparatus</json:string>
<json:string>uptake assay</json:string>
<json:string>cytolytic activity</json:string>
</teeft>
</keywords>
<author><json:item><name>JOHN C. HISERODT</name>
<affiliations><json:string>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592</json:string>
</affiliations>
</json:item>
<json:item><name>WILLIAM H. CHAMBERS</name>
<affiliations><json:string>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592</json:string>
</affiliations>
</json:item>
</author>
<articleId><json:string>NYAS395</json:string>
</articleId>
<arkIstex>ark:/67375/WNG-XRJKTC7V-L</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>article</json:string>
</originalGenre>
<qualityIndicators><score>6.475</score>
<pdfWordCount>4463</pdfWordCount>
<pdfCharCount>22728</pdfCharCount>
<pdfVersion>1.4</pdfVersion>
<pdfPageCount>10</pdfPageCount>
<pdfPageSize>417.119 x 649.2 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractWordCount>1</abstractWordCount>
<abstractCharCount>0</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity</title>
<pmid><json:string>3052213</json:string>
</pmid>
<genre><json:string>article</json:string>
</genre>
<host><title>Annals of the New York Academy of Sciences</title>
<language><json:string>unknown</json:string>
</language>
<doi><json:string>10.1111/(ISSN)1749-6632</json:string>
</doi>
<issn><json:string>0077-8923</json:string>
</issn>
<eissn><json:string>1749-6632</json:string>
</eissn>
<publisherId><json:string>NYAS</json:string>
</publisherId>
<volume>532</volume>
<issue>1</issue>
<pages><first>395</first>
<last>404</last>
<total>10</total>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<namedEntities><unitex><date><json:string>1988</json:string>
</date>
<geogName></geogName>
<orgName></orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName></persName>
<placeName><json:string>Cytotoxicity</json:string>
<json:string>YORK</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl></ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/WNG-XRJKTC7V-L</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - multidisciplinary sciences</json:string>
</wos>
<scienceMetrix><json:string>1 - general</json:string>
<json:string>2 - general science & technology</json:string>
<json:string>3 - general science & technology</json:string>
</scienceMetrix>
<scopus><json:string>1 - Social Sciences</json:string>
<json:string>2 - Arts and Humanities</json:string>
<json:string>3 - History and Philosophy of Science</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - General Biochemistry, Genetics and Molecular Biology</json:string>
</scopus>
</categories>
<publicationDate>1988</publicationDate>
<copyrightDate>1988</copyrightDate>
<doi><json:string>10.1111/j.1749-6632.1988.tb36357.x</json:string>
</doi>
<id>63BCE4B9204D80FCA9A3521E82CB3124983E81A2</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/63BCE4B9204D80FCA9A3521E82CB3124983E81A2/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/63BCE4B9204D80FCA9A3521E82CB3124983E81A2/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/63BCE4B9204D80FCA9A3521E82CB3124983E81A2/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1988-08"></date>
</publicationStmt>
<notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity</title>
<author xml:id="author-0000"><persName><forename type="first">JOHN C.</forename>
<surname>HISERODT</surname>
</persName>
<affiliation>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592<address><country key="US"></country>
</address>
</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">WILLIAM H.</forename>
<surname>CHAMBERS</surname>
</persName>
<affiliation>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592<address><country key="US"></country>
</address>
</affiliation>
</author>
<idno type="istex">63BCE4B9204D80FCA9A3521E82CB3124983E81A2</idno>
<idno type="ark">ark:/67375/WNG-XRJKTC7V-L</idno>
<idno type="DOI">10.1111/j.1749-6632.1988.tb36357.x</idno>
<idno type="unit">NYAS395</idno>
<idno type="toTypesetVersion">file:NYAS.NYAS395.pdf</idno>
</analytic>
<monogr><title level="j" type="main">Annals of the New York Academy of Sciences</title>
<title level="j" type="alt">ANNALS OF NEW YORK ACADEMY SCIENCES</title>
<idno type="pISSN">0077-8923</idno>
<idno type="eISSN">1749-6632</idno>
<idno type="book-DOI">10.1111/(ISSN)1749-6632</idno>
<idno type="book-part-DOI">10.1111/nyas.1988.532.issue-1</idno>
<idno type="product">NYAS</idno>
<idno type="publisherDivision">ST</idno>
<imprint><biblScope unit="vol">532</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="395">395</biblScope>
<biblScope unit="page" to="404">404</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1988-08"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/63BCE4B9204D80FCA9A3521E82CB3124983E81A2/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1749-6632</doi>
<issn type="print">0077-8923</issn>
<issn type="electronic">1749-6632</issn>
<idGroup><id type="product" value="NYAS"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup><title type="main" sort="ANNALS OF NEW YORK ACADEMY SCIENCES">Annals of the New York Academy of Sciences</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="08001"><doi origin="wiley">10.1111/nyas.1988.532.issue-1</doi>
<titleGroup><title type="main">Cytotoxic T Cells: Biology and Relevance to Disease</title>
</titleGroup>
<numberingGroup><numbering type="journalVolume" number="532">532</numbering>
<numbering type="journalIssue">1</numbering>
</numberingGroup>
<coverDate startDate="1988-08">August 1988</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="40" status="forIssue"><doi origin="wiley">10.1111/j.1749-6632.1988.tb36357.x</doi>
<idGroup><id type="unit" value="NYAS395"></id>
</idGroup>
<countGroup><count type="pageTotal" number="10"></count>
</countGroup>
<titleGroup><title type="tocHeading1">PART VI. MOLECULAR ASPECTS OF CYTOTOXIC T LYMPHOCYTES AND EFFECTS ON TUMOR GROWTH</title>
</titleGroup>
<eventGroup><event type="firstOnline" date="2006-12-17"></event>
<event type="publishedOnlineFinalForm" date="2006-12-17"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.6 mode:FullText source:HeaderRef result:HeaderRef" date="2010-04-21"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-19"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst" number="395">395</numbering>
<numbering type="pageLast" number="404">404</numbering>
</numberingGroup>
<linkGroup><link type="toTypesetVersion" href="file:NYAS.NYAS395.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="referenceTotal" number="78"></count>
<count type="linksCrossRef" number="2"></count>
</countGroup>
<titleGroup><title type="main">Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity</title>
</titleGroup>
<creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>JOHN C.</givenNames>
<familyName>HISERODT</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>WILLIAM H.</givenNames>
<familyName>CHAMBERS</familyName>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="a1" countryCode="US"><unparsedAffiliation>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592</unparsedAffiliation>
</affiliation>
</affiliationGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity</title>
</titleInfo>
<name type="personal"><namePart type="given">JOHN C.</namePart>
<namePart type="family">HISERODT</namePart>
<affiliation>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">WILLIAM H.</namePart>
<namePart type="family">CHAMBERS</namePart>
<affiliation>Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15213–2592</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre>
<originInfo><publisher>Blackwell Publishing Ltd</publisher>
<place><placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">1988-08</dateIssued>
<copyrightDate encoding="w3cdtf">1988</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><extent unit="references">78</extent>
<extent unit="linksCrossRef">2</extent>
</physicalDescription>
<relatedItem type="host"><titleInfo><title>Annals of the New York Academy of Sciences</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<identifier type="ISSN">0077-8923</identifier>
<identifier type="eISSN">1749-6632</identifier>
<identifier type="DOI">10.1111/(ISSN)1749-6632</identifier>
<identifier type="PublisherID">NYAS</identifier>
<part><date>1988</date>
<detail type="title"><title>Cytotoxic T Cells: Biology and Relevance to Disease</title>
</detail>
<detail type="volume"><caption>vol.</caption>
<number>532</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>395</start>
<end>404</end>
<total>10</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">63BCE4B9204D80FCA9A3521E82CB3124983E81A2</identifier>
<identifier type="ark">ark:/67375/WNG-XRJKTC7V-L</identifier>
<identifier type="DOI">10.1111/j.1749-6632.1988.tb36357.x</identifier>
<identifier type="ArticleID">NYAS395</identifier>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource>
<recordOrigin>Blackwell Publishing Ltd</recordOrigin>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/document/63BCE4B9204D80FCA9A3521E82CB3124983E81A2/metadata/json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001693 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001693 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:63BCE4B9204D80FCA9A3521E82CB3124983E81A2
   |texte=   Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity
}}

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021

	Serveur d'exploration sur Pittsburgh
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur Pittsburgh

Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity

Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri